Water Island Capital »

Biomarin Pharma Inc convertible/ shares owned by Water Island Capital

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Water Island Capital from 13F filings

Historical chart of Water Island Capital investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Water Island Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Water Island Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.3M 7.4M 0.99

More positions owned by Water Island Capital

Amedisys Equity (AMED)
Hess Corp Equity (HES)
Axonics Equity (AXNX)
Hashicorp Equity (HCP)
Albertsons Cos Equity (ACI)
Ansys Equity (ANSS)
Olink Hldg Ab Equity (OLK)
Squarespace Equity (SQSP)
Championx Corporation Equity (CHX)
Vizio Hldg Corp Equity (VZIO)
United States Stl Corp Equity (X)
Marathon Oil Corp Equity (MRO)
Juniper Networks Equity (JNPR)
Cerevel Therapeutics Hldng I Equity (CERE)
Mcgrath Rentcorp Equity (MGRC)

View all positions for Water Island Capital

Top funds holding Biomarin Pharma Inc convertible/

Osterweis Capital Management
Aviva
Piper Jaffray & Co.
State Street Corporation
Branch Banking & Trust Company
Kohlberg Kravis Roberts & Co
Palisade Capital Management
Water Island Capital
Macquarie Group
Morgan Stanley
Prospector Partners
Russell Investments
Fox Hill Wealth Management

View all funds holding Biomarin Pharma Inc convertible/